Pricing Log in Create free account

CervoMed Inc. (CRVO) vs Lite Strategy, Inc. (LITS)

CervoMed Inc. and Lite Strategy, Inc. are both Biotechnology companies. CervoMed Inc. and Lite Strategy, Inc. are of similar size ($36.3M and $34.0M). Lite Strategy, Inc. grew revenue faster over the last twelve months: 152.9% against −58.9%. Across the 13 metrics below, CervoMed Inc. leads on 7 and Lite Strategy, Inc. on 6.

Valuation

Metric CRVO LITS Biotechnology median
P/E n/m n/m 8.50
P/S 5.73 0.37 9.71
P/B 1.00 0.95 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 2.74 0.32 9.21
Earnings yield (143.75%) (179.62%) (33.15%)
Free cash flow yield (123.82%) (264.16%) (25.50%)

Profitability

Metric CRVO LITS Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (107.62%) (243.02%) (56.36%)
Return on assets (94.73%) (233.37%) (48.04%)
Return on invested capital 0.00% (115.85%) 0.00%

Growth

Metric CRVO LITS Biotechnology median
Revenue growth (TTM) (58.86%) 152.90% 6.02%
EPS growth (last fiscal year) (47.52%) 13.86% 30.26%
Revenue growth, 5-year CAGR — 67.75% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRVO LITS Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.57 5.74 4.72
Net debt to EBITDA 0.74 0.09 0.96

Dividend

Metric CRVO LITS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CRVO LITS Biotechnology median
Market cap 34.02m 36.34m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack